Standout Papers
- The molecular biology of chronic myeloid leukemia (2000)
- Chronic Myeloid Leukemia — Advances in Biology and New Approaches to Treatment (2003)
- Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistance (2000)
- Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study (2013)
- The Tyrosine Kinase Inhibitor CGP57148B Selectively Inhibits the Growth of BCR-ABL–Positive Cells (1997)
Immediate Impact
5 by Nobel laureates 13 from Science/Nature 118 standout
Citing Papers
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells
2017 Standout
Works of Junia V. Melo being referenced
Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
2013 Standout
In search of the original leukemic clone in chronic myeloid leukemia patients in complete molecular remission after stem cell transplantation or imatinib
2010
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Junia V. Melo | 7131 | 5468 | 3166 | 119 | 10.0k | |
| Tessa L. Holyoake | 7343 | 4623 | 2075 | 216 | 10.9k | |
| Hagop Kantarjian | 4871 | 3143 | 1569 | 128 | 7.3k | |
| Dan Jones | 4534 | 3883 | 2241 | 251 | 8.4k | |
| Susan Branford | 9410 | 7927 | 5224 | 199 | 10.7k | |
| Claudia Schoch | 8724 | 3342 | 1000 | 194 | 11.2k | |
| Miloslav Beran | 5188 | 3342 | 728 | 106 | 8.4k | |
| François‐Xavier Mahon | 5480 | 4381 | 2537 | 204 | 6.8k | |
| George S. Vassiliou | 4123 | 4310 | 1590 | 105 | 8.1k | |
| Eva Hellström‐Lindberg | 8074 | 3759 | 492 | 184 | 10.4k | |
| Róbert Královics | 5210 | 7012 | 2791 | 132 | 9.6k |
All Works
Loading papers...